Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1038/sj.gt.3302285PMID 15103321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiostatin and Endostatin: Endogenous Inhibitors of Tumor Growth

  2004cited by this paper
• Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer

  2004cited by this paper
• Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)).

  2003cited by this paper
• In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.

  2003cited by this paper
• Polycation liposome-mediated gene transfer in vivo.

  2003cited by this paper
• Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas

  2002cited by this paper
• Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

  2002cited by this paper
• Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation.

  2002cited by this paper
• Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.

  2002cited by this paper
• Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice

  2002cited by this paper
• Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.

  2001cited by this paper
• Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival

  2001cited by this paper
• Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.

  2001cited by this paper
• Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease

  2001cited by this paper
• Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum.

  2001cited by this paper
• Cancer gene therapy by adenovirus-mediated gene transfer.

  2001cited by this paper
• Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo.

  2000cited by this paper
• Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles

  2000cited by this paper
• Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.

  2000cited by this paper
• Impact of genomics on drug discovery and clinical medicine.

  2000cited by this paper
• HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.

  2000cited by this paper
• Efficient gene transfer by histidylated polylysine/pDNA complexes.

  1999cited by this paper
• Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer.

  1999cited by this paper
• Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

  1998cited by this paper
• Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor

  1998cited by this paper
• The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).

  1998cited by this paper
• Three-dimensional electrophysiological imaging of the intact canine left ventricle using a noncontact multielectrode cavitary probe: study of sinus, paced, and spontaneous premature beats.

  1998cited by this paper
• Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

  1998cited by this paper
• Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.

  1998cited by this paper
• Protein release from gelatin matrices.

  1998cited by this paper
• Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration.

  1997cited by this paper
• Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.

  1997cited by this paper
• HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor

  1997cited by this paper
• In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration.

  1996cited by this paper
• Angiostatin induces and sustains dormancy of human primary tumors in mice

  1996cited by this paper
• Glycerol enhancement of ligand-polylysine/DNA transfection.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis

  1996cited by this paper
• Scatter factor and angiogenesis.

  1995cited by this paper
• Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

  1995cited by this paper
• The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

  1995cited by this paper
• Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats.

  1995cited by this paper
• The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.

  1995cited by this paper
• Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo

  1992cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• In vitro iodination of low complexity nucleic acids without chain scission.

  1976cited by this paper
• An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

  1975cited by this paper

• Micro- and nanoformulations of functionalized biopolymers in neurodegenerative diseases, diabetes, cancer, microbial infections, and regenerative medicine: A comprehensive review.

  2025cites this paper
• The Transfer of the Hepatocyte Growth Factor Gene by Macrophages Ameliorates the Progression of Peritoneal Fibrosis in Mice

  2023cites this paper
• Green Synthesis of Gelatin‐Lipid Nanocarriers Incorporating Berberis aristata Extract for Cancer Therapy; Physical Characterization, Pharmacological and Molecular Modeling Analysis

  2022cites this paper
• Encapsulation with Natural Polymers to Improve the Properties of Biostimulants in Agriculture

  2022cites this paper
• Fate of Biomaterials Post Payload Delivery: Current Understanding and Future Perspectives

  2021cites this paper
• Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia

  2020cites this paper
• Synthesis and Applications of Hydrogels in Cancer Therapy.

  2020cites this paper
• Gelatin modified lipid nanoparticles for anti- viral drug delivery.

  2017cites this paper
• Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats☆

  2016cites this paper
• Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.

  2016cites this paper
• How controlled release technology can aid gene delivery

  2015cites this paper
• Endogenous Polymers as Biomaterials for Nanoparticulate Gene Therapy

  2015cites this paper
• Genetic Vaccines and Therapy

  2015cites this paper
• Synthesis, Characterization and In Vitro Drug Release of Melphalan Magnetic Microspheres

  2013cites this paper
• Proteins: emerging carrier for delivery of cancer therapeutics

  2013cites this paper
• Engineering of magnetic DNA nanoparticles for tumor-targeted therapy

  2013cites this paper
• Preparation and in vitro release properties of mercaptopurine drug-loaded magnetic microspheres

  2013cites this paper
• HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics

  2013cites this paper
• HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice.

  2012cites this paper
• Preparation of Biodegradable Gelatin Nanospheres with a Narrow Size Distribution for Carrier of Cellular Internalization of Plasmid DNA

  2012cites this paper
• Gelatin nanospheres incorporating siRNA for controlled intracellular release.

  2012cites this paper
• NK 4 Gene Therapy Combined with Cisplatin Inhibits Tumour Growth and Metastasis of Squamous Cell Carcinoma

  2011cites this paper
• NK4 gene therapy combined with cisplatin inhibits tumour growth and metastasis of squamous cell carcinoma.

  2011cites this paper
• Evaluation of blood compatibility and drug release studies of gelatin based magnetic hydrogel nanocomposites

  2011cites this paper
• Epithelial and Mesenchymal Cell Biology Involvement of Wnt Signaling in Dermal Fibroblasts

  2010cites this paper
• Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

  2010cites this paper
• Anti-cancer approach with NK4: Bivalent action and mechanisms.

  2010cites this paper
• Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours

  2009cites this paper
• Suppression of growth of Hela, EJ, SK-OV-3 and MDA-MB-231 cells by recombinant human NK4

  2009cites this paper
• Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model

  2009cites this paper
• Biomaterial technology for tissue engineering applications

  2009cites this paper
• NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells

  2009cites this paper
• Gelatin-based delivery systems for cancer gene therapy

  2009influential citation
• MET as a target for treatment of chest tumors.

  2009cites this paper
• Dual-role self-assembling nanoplexes for efficient gene transfection and sustained gene delivery.

  2008cites this paper
• NK4 gene therapy targeting HGF-Met and angiogenesis.

  2008cites this paper
• Tissue Engineering of Internal Medicine for Regeneration Therapy of Chronic Fibrotic Diseases

  2008cites this paper
• Chapter 8 – Angiogenesis

  2008cites this paper
• Drug releasing systems in cardiovascular tissue engineering

  2008cites this paper
• Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4

  2008cites this paper
• Development of a novel antimicrobial peptide, AG-30, with angiogenic properties

  2008cites this paper
• Synthetic sustained gene delivery systems.

  2008cites this paper
• Non-viral gene transfection technologies for genetic engineering of stem cells.

  2008cites this paper
• Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.

  2008influential citation
• Microfabricated airflow nozzle for microencapsulation of living cells into 150 micrometer microcapsules

  2007cites this paper
• Drug delivery systems for the treatment of sensorineural hearing loss

  2007cites this paper
• Suppression of Renal Tubulointerstitial Fibrosis by Small Interfering RNA Targeting Heat Shock Protein 47

  2007cites this paper
• Expression of c-Met and HGF in non-small cell lung carcinomas

  2007cites this paper
• In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds

  2006cites this paper
• Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect.

  2006cites this paper
• Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro.

  2006cites this paper
• Gene Transfer Using Nonviral Delivery Systems

  2006cites this paper
• Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.

  2006cites this paper
• Non‐viral vectors for cancer therapy

  2006cites this paper
• Effect of charge and molecular weight on the functionality of gelatin carriers for corneal endothelial cell therapy.

  2006cites this paper
• Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma

  2006cites this paper
• TECHNOLOGICAL ADVANCES IN PERITONEAL DIALYSIS RESEARCH

  2006cites this paper
• Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.

  2006cites this paper
• Retraction Note: Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation

  2006cites this paper
• Tissue engineering by modulated gene delivery.

  2006cites this paper
• Successful gene transfer into dendritic cells with cationized gelatin and plasmid DNA complexes via a phagocytosis-dependent mechanism.

  2006cites this paper
• Effect of solution composition of plasmid DNA on gene transfection following liver surface administration in mice.

  2005cites this paper
• Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation

  2005cites this paper
• In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels.

  2005cites this paper
• Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation.

  2005cites this paper
• Mechanisms and significance of bifunctional NK4 in cancer treatment.

  2005cites this paper
• Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.

  2005cites this paper
• In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.

  2005cites this paper
• Gelatin as a delivery vehicle for the controlled release of bioactive molecules.

  2005cites this paper
• Targeting of plasmid DNA to renal interstitial fibroblasts by cationized gelatin.

  2005cites this paper
• Controlled release of plasmid DNA by cationized gelatin hydrogel

  2004cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper
• Ijpbs |volume 2| Issue 3 |july-sept |2012|183-192 a Review: a Novel Gelatin Based Delivery Systems for Gene Therapy and Paclitaxel Targeting Cancer Cells

  year unknowncites this paper